BARCLAYS PLC - AGEX THERAPEUTICS INC ownership

AGEX THERAPEUTICS INC's ticker is AGE and the CUSIP is 00848H108. A total of 61 filers reported holding AGEX THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of AGEX THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$64,000
-4.5%
41,1000.0%0.00%
Q1 2021$67,000
+8.1%
41,1000.0%0.00%
Q4 2020$62,000
+87.9%
41,1000.0%0.00%
Q3 2020$33,000
-26.7%
41,100
-12.9%
0.00%
Q2 2020$45,000
+2.3%
47,191
-2.0%
0.00%
Q1 2020$44,000
+12.8%
48,153
+126.4%
0.00%
Q4 2019$39,000
+85.7%
21,273
+101.0%
0.00%
Q3 2019$21,000
-58.0%
10,584
-23.4%
0.00%
Q2 2019$50,000
+163.2%
13,811
+180.1%
0.00%
Q1 2019$19,0004,930
+1980.2%
0.00%
Q4 2018$02370.00%
Other shareholders
AGEX THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Defender Capital, LLC. 346,805$1,379,0001.31%
BROADWOOD CAPITAL INC 2,997,156$8,961,0001.26%
Price Capital Management, Inc. 70,122$210,0000.29%
Prescott General Partners LLC 185,185$554,0000.02%
Destination Wealth Management 34,703$104,0000.01%
STATE OF WISCONSIN INVESTMENT BOARD 472,239$1,412,0000.01%
AXA S.A. 121,258$363,0000.00%
Riggs Asset Managment Co. Inc. 1,160$3,0000.00%
Banco de Sabadell, S.A 2,000$6,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 24,070$72,0000.00%
View complete list of AGEX THERAPEUTICS INC shareholders